Nephros shareholders elect Astor and Lask as directors, ratify auditor, approve say-on-pay

NEPHROS INC

At May 19, 2022 annual meeting, Andrew Astor and Alisa Lask elected to three-year board terms (6.2M for each; 2.3M broker non-votes).
Ratification of Baker Tilly US, LLP as independent auditor for FY2022 passed with 8,637,438 for, 17,548 against, 1,177 abstain.
Advisory (non-binding) approval of named executive officer compensation passed with 6,093,819 for, 216,653 against, 12,642 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.